Seven-year overall survival of trastuzumabe versus alternative systemic therapies in a Brazilian breast cancer cohort

Seven-year overall survival of trastuzumabe versus alternative systemic therapies in a Brazilian breast cancer cohort

Abstract This study analyzed breast cancer patients treated with trastuzumab in Brazil’s unified health system (SUS) from 2008 to 2015. A non-concurrent cohort study using SUS data applied propensity score matching to reduce bias between trastuzumab and non-trastuzumab groups. Survival probabilities...

Full description

Bibliographic Details
Main Authors: Thaís Monteiro Alves, Wallace Mateus Prata, Marcus Carvalho Borin, Alexandre Ribas de Carvalho, Carolina Zampirolli Dias, Mariangela Leal Cherchiglia, Luiza Ohasi de Figueiredo, Francisco de Assis Acurcio, Juliana Alvares-Teodoro, Augusto Afonso Guerra Júnior
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Trastuzumab
Breast neoplasms
Survival
Pharmacoepidemiology
Online Access:https://doi.org/10.1038/s41598-025-88575-3

Internet

https://doi.org/10.1038/s41598-025-88575-3

Similar Items